SLS SELLAS Life Sciences Group, Inc.
Stable Earnings Power
F 21.3 / 100 pillar composite

AlphaQuality composite grade, weighted for stable earnings power businesses.

⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.

Grade overrides the 21.3 pillar composite — hard gates always win.

Profitability

Weight: 20%
F 0
  • 5yr Avg ROIC -192.8%

Capital Efficiency

Weight: 15%
F 0
  • 5yr Avg ROE -329.3%
  • 5yr Share-Count CAGR 68.7%

Growth Quality

Weight: 15%
F 20
  • Revenue-Growth Years (5) 1/5

Cash Generation

Weight: 15%
F 0
  • 5yr FCF Margin -1586.6%
  • 5yr FCF/NI Conversion 0.00x

Balance Sheet

Weight: 20%
C 55
  • Net Debt / EBITDA 10.00x
  • Interest Coverage (EBIT/Int) 30.00x
  • Altman Z-Score 167.42

Stability

Weight: 15%
C- 48
  • Negative-Revenue Years (5) 1/5
  • Piotroski F-Score 2

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Accumulating

2 of 2 gurus held; 2 new buys.

Holders
2 +2
Avg Δ position
New buys
2
Full exits
0
As of Q2 2026